PATENT CLAIM ANALYSIS

Application Number: 16099353
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to a new therapeutic application of pharmaceutically acceptable carriers containing miR222. In particular, the invention relates to the use of extracellular vesicles (EVs) which contain the microRNA miR222, in the treatment of fibrotic disease caused by hyperglycaemia, such as diabetic nephropathy and/or renal fibrosis.

Claim (Index 6):
The pharmaceutically acceptable carrier for use according to  claim 5 , wherein the extracellular vesicle (EV) is derived from an adult stem cell.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15841709', '15545937', '14848085', '16086736', '15278568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7163547465304029
- 35 USC 102 Novelty (BERT): 0.5018845151240249
- Combined Prediction Score: 0.694907723389765
- Mean Citation Score: 179.04799599999996
- Max Citation Score: 213.83273
- Similarity Product: 151.00877666431307

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test